Cefotetan disodium-induced hemolytic anemia.

Author: FlinkJ R, HeatonA H, WagnerB K

Paper Details 
Original Abstract of the Article :
OBJECTIVE: To report a case of cefotetan disodium-induced hemolytic anemia. DATA SOURCES: Original research articles and case reports. DATA SYNTHESIS: A 46-year-old woman developed fulminant hemolytic anemia following a second exposure to intravenous cefotetan disodium for postoperative prophylaxi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1177/106002809202600213

データ提供:米国国立医学図書館(NLM)

Cefotetan Disodium-Induced Hemolytic Anemia: A Case Report

This case report explores a rare and potentially life-threatening complication associated with the use of cefotetan disodium, an antibiotic used to treat bacterial infections. Cefotetan is a broad-spectrum antibiotic that is commonly used for surgical prophylaxis and the treatment of various infections. The researchers aimed to report a case of fulminant hemolytic anemia, a condition characterized by the rapid destruction of red blood cells, in a patient who had received cefotetan disodium.

The case report describes a 46-year-old woman who developed fulminant hemolytic anemia following a second exposure to intravenous cefotetan disodium. She experienced respiratory failure, acute renal failure, and required intubation and hemodialysis. While plasmapheresis successfully treated the hemolysis, the patient unfortunately died on the 25th postoperative day. This case highlights the potential for cefotetan disodium to cause hemolytic anemia, a serious complication that can lead to life-threatening consequences.

Cefotetan Disodium: A Potential Risk of Hemolytic Anemia

This case report emphasizes the importance of being aware of the potential for cefotetan disodium to cause hemolytic anemia. Healthcare providers should carefully monitor patients receiving this medication for signs of hemolysis, such as fatigue, shortness of breath, and jaundice. Patients should be informed of the potential risks of cefotetan disodium and report any unusual symptoms or changes in their health to their healthcare providers.

Navigating Antibiotic Use: A Journey of Informed Decision-Making

This case report underscores the importance of informed decision-making in the use of antibiotics. Healthcare providers should carefully consider the potential risks and benefits of antibiotics, including the potential for rare but serious adverse events like hemolytic anemia. Patients should be actively involved in their treatment plan and be informed about the potential risks and side effects of their medications.

Dr. Camel's Conclusion

This case report serves as a reminder that even common medications can have unexpected and potentially serious side effects. Just as a traveler in the desert must be wary of hidden dangers, healthcare providers must be vigilant in monitoring patients for adverse events. This case underscores the importance of careful consideration and open communication between patients and healthcare professionals to ensure the safe and effective use of medications.

Date :
  1. Date Completed 1992-05-04
  2. Date Revised 2017-02-14
Further Info :

Pubmed ID

1554932

DOI: Digital Object Identifier

10.1177/106002809202600213

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.